Business Strategy And The Strategic Moves Of Pfizer

Business Strategy The paper is going to discuss the business strategy and the strategic moves of Pfizer in trying to buy AstraZeneca. In addition, the paper will broadly talk about the environment (PEST analysis), the industry (Porter analysis), and stakeholder influence and business idea concerning AstraZeneca. . It will also demonstrate how the capabilities/ resources and competencies of the company projects are evaluated using the SWOT analysis and the value chain. It will also show some options that are strategic which are available to the company with the motive. Introduction AstraZeneca has a vision of becoming a company which is most valued by businesses, customers and patients. The company also has a mission of establishing medicines with a main and purpose of treating and curing diseases, sufferings and symptoms. The company was founded by two cousins in the year 1849 and in the year 1900 it was converted from a business of the family to incorporation. In addition in the year 1944 it became the leading producer of penicillin and citric acid (Thayer 92). Literature Review The research has made use of a number of academic sources so as to get some historical and current information concerning the topic. The importance of using the academic sources is that they are reliable and contain information that has been gathered by many writers thus making the research very successful. TheShow MoreRelatedThe Strategic Plan of Pfizer Incorporated: A Research1858 Words   |  7 Pagesï » ¿ Strategic Plan of Pfizer Pfizer Brief Company Profile Pfizer Inc is a multinational investment company. It ventures in the medical and pharmaceutical industry. It is renowned as a giant pharmaceutical company, founded in 1849. It is based in the United States, New York, Manhattan at Midtown. It is the largest universal producer and trader of pharmaceuticals (Turner, 2005, pg 161). Some of the products availed to the market by the company are Lipitor, Lyrica, Diflucan, Zithromax, Zoloft,Read MorePfizer Analysis Essay1399 Words   |  6 PagesPFIZER ANALYSIS INTRODUCTION Pfizer is the largest American pharmaceutical company and one of the largest pharmaceutical companies in the world. It competes with Merck and Glaxo, and markets such well-known medications as Celebrex and Viagra. However, the pharmaceutical industry as a whole has undergone changes in recent years with significant consolidation taking place and with increased scrutiny regarding the ways in which drugs are developed, tested and marketed. In addition, recent controversiesRead MorePfizer Analysis Essay1402 Words   |  6 PagesPfizer Analysis INTRODUCTION Pfizer is the largest American pharmaceutical company and one of the largest pharmaceutical companies in the world. It competes with Merck and Glaxo, and markets such well-known medications as Celebrex and Viagra. However, the pharmaceutical industry as a whole has undergone changes in recent years with significant consolidation taking place and with increased scrutiny regarding the ways in which drugs are developed, tested and marketed. In addition, recent controversiesRead MorePfizer Case Study Essay5236 Words   |  21 PagesPfizer – Written Case Report Prepared by: BAMG 456-023: Strategic Management amp; Business Policy (Fall 2012) Table of Contents: 1. Part One: Evaluation of the External Environment a. Introduction 4 b. Opportunities and Threats 6 i. Assessment of Societal (Remote) Environment ii. Assessment of Industry (Task) Environment iii. Assessment of Competition (Bryan Jenkins) iv. Overall Opportunities and Threats and Score 2Read MoreContemporary Issues in Financial Management3088 Words   |  12 PagesCorporate governance: 5 Selected contemporary issue: 6 Company Background: 7 Financial strategy: 8 Impacts of acquisition on ethical issues: 9 Financial situation prior to acquisition: 10 Financial situation after the acquisition: 10 Successful management of Acquisition: 11 Conclusion: 12 References: 14 Introduction: The finance and corporate management requires a strong hold of business processes approach towards handling certain transactions related to Multinational mergers andRead MoreStrategic Analysis for Pfizer Company4528 Words   |  19 PagesStrategic Analysis for Pfizer Incorporated Strategic Analysis Competition, typically the most powerful external force, is increased by the advent of globalization. The number of companies and the number of countries where these companies operate and the way governments are dealing with the impacts of globalization is accelerating. The interaction of changes in government policy and business innovation has actually made globalization even faster. If a company does not become a global, it wouldRead MorePfizer to Acquire Protalix10020 Words   |  41 PagesBackground I C. The Rational for the Acquisition I D. Standalone, Synergy and Premium Valuations II E. Integration Plan II Part 1 - The Rational of the Acquisition 1 1. Pfizers Strategy 1 1.1. Pfizer Growth Strategy 2 2. Pfizers Road Map 4 2.1. Pfizers Acquisitions Rational 4 3. The strategy behind the acquisition 5 3.1. Acquisition Motives 5 3.2. Mamp;A vs.  Alliance 5 4. Target Identification 7 4.1. Protalix - an Ramp;D Acquisition 9 5. Synergy Analysis 10 6. StandaloneRead MorePfizers Strategic Plan Essay3949 Words   |  16 PagesPFIZER INC. Pfizer Strategic Plan Date Submitted: May 25, 2005 Pfizers Strategic Plan: Overview Executive Summary Pfizer is a New York City based major drug producer, ranking first in pharmaceutical sales in the U.S., with 2005 revenues of 56.7 billion. With almost 60 billion in Revenue, Pfizer remains the industrys behemoth, overseeing the most ambitious research agenda for any company in the world. Pfizers is spending on RD supports 12,000 scientists. Pfizers research increased 3Read MoreThe Current Strategy Of Pfizers Operation1780 Words   |  8 PagesCurrent Strategy The current strategy of Pfizer’s operation has been organized in three operating units. These three segments are Global Innovative Pharmaceutical (GIP), Oncology and Consumer (VOX) and Global Established Pharmaceutical (GEP). GEP, GIP and VOX operating structure is subject to Pfizer’s future strategy. The units have been structured to either be combined with another pharmaceutical firm in a megamerger consolidation to reap economies of scale or to split off as separate entitiesRead MoreCase Study of Pharmaceutical Industry3196 Words   |  13 Pagesnegate the effects of supplier choice. Bargaining Power of Customers Patents lasting 20 years after drug invention mean that the company can dictate price and supply during that period, however once the patent finishes, generic drug producing firms can move in consequently placing more power in the consumers hand Threat of Substitutes There is a medium to high threat of substitutes in the pharmaceutical industry coming from the threat of generic branded drugs once patents run out and also from alternative